Cognizant Services provides automation and digital technologies that can reduce the cost of services and speed time to market.
teaneck new jersey
,
March 25, 2024
/PRNewswire/ —
It has recognized
(NASDAQ: CTSH) today announced that
Clario
is a healthcare research technology company that provides cutting-edge endpoint technology solutions for clinical trials to support global IT infrastructure and applications. This collaboration will help Clario better serve its employees and customers in support of Clario's mission to transform lives by generating high-quality evidence for more informed decision-making. Helpful.
“At Clario, we pride ourselves on providing our customers with the best technology, and we do that by building a robust and innovative ecosystem.”
Jay Ferro
, Vice President and Chief Information, Technology and Product Officer, Clario. “Cognizant's innovative technology and industry expertise made it a natural choice to partner with us on the next stage of our digital transformation journey.”
Clario develops digital solutions that redefine what's possible in clinical trials by improving the accuracy, reliability, speed, and efficiency of data collection and analysis. Throughout the five-year relationship, Clario leverages Cognizant's experience in automation and digital technologies to modernize processes and experiences to support:
-
Accelerate time to market by streamlining workflows and increasing collaboration between teams.
-
Build the foundation of your digital enterprise by unifying data, analytics, and AI capabilities across your enterprise.
-
We drive cutting-edge innovation in the clinical trial space by adopting agile methodologies and best practices.
“Clinical trials require safe and reliable technology to manage patient data, monitor results, ensure regulatory compliance, and more,” Cognizant said.
Mohammad Haq
, Senior Vice President, Global Large Deal Lead, Head of BU, Life Sciences. “Clario is doing groundbreaking work in providing this technology to conduct clinical trials, and Cognizant is excited to work with them to modernize our product.”
About Cognizant
Cognizant (NASDAQ: CTSH) is architecting modern business. We help our clients modernize technology, reimagine processes, transform experiences, and stay ahead in a rapidly changing world. Together we will improve everyday life.See how
www.cognizant.com
Or @cognizant.
About Clario
Clario is a leading healthcare research and technology company that generates the highest quality clinical evidence for pharmaceutical, biotech, and medical device partners. These provide a comprehensive evidence generation solution that combines eCOA, cardiac safety, medical imaging, precision motion, and respiratory endpoints.
Clario's global team of scientific, technical and operational experts has helped conduct more than 26,000 clinical trials and contributed to more than 800 regulatory approvals in more than 100 countries. For more than 50 years, he has provided deep scientific expertise and the most comprehensive endpoint technology to help transform lives around the world.
View original content to download multimedia: https://www.prnewswire.com/news-releases/clario-selects-cognizant-as-global-strategic-technology-services-provider-to- optimize-and-advance-their-clinical -transformation journey-302097723.html
SOURCE Cognizant Technology Solutions, Inc.
